clarify reasons why Q3/2019’s profit showed changing over 20% as follows. 1. Revenue from sales In Q3/2019, the company’s revenue from sale was 1,213.63 million baht increased from 959.17 million baht

-month (Thousands Baht) Change Amount % Revenue from sales , , , .% Other income , , , .% Total Revenue , , , .% Company revenue slightly increased 1.89 percent from the same period of last year, due to

- Translation - MPIC 002/2018 February 14, 2018 Subject: Submit the Year End Financial Statement ended December 31, 2017 and clarification for the change of operating result more than 20% Attention

incurred from deferred tax. This extra transaction was included in year ended 2017 financial statement for the net amount of THB 24 million. Revenue from Hospital Operations Revenue from hospital operations

the growth rate of company’s revenue; therefore, SG&A/Sales decrease from 11.06% in Q1/2018 to 10.13% in Q1/2019. 3. Financial Expenses The financial expenses in Q1/2019 were 5.94 million baht increased

(Thailand) Public Company Limited (“INGRS”or “the Company”) would like to provide an explanation about our 3-months financial performance for the period ended 30 April 2019: 1. Sales Revenue For the 3-months

: The Director and Manager The Stock Exchange of Thailand The Company would like to report the operating results for the 2nd Quarter ended June 30, 2018 that total revenue was at THB8.94 million

. Total sales revenue and service was 144.34 million Baht, decreased 187.86 million Baht or 56.55% from the same period last year due to the Company and its subsidiary received decreased orders from

rate of increase is less than the growth rate of company’s revenue; therefore, SG&A/Sales decrease from 11.61% in Q2/2017 to 11.12% in Q2/2018. 3. Financial Expenses The financial expenses in Q2/2018

results of the year ended December 31, 2018 according to the regulation of The Stock Exchange of Thailand as follow: 1. Total sales revenue and service was 264.24 million Baht, decreased 402.64 million Baht